Company Filing History:
1 out of 517 
1 out of 72 
Years Active: 2000
Title: Scott Pluskey: Innovator in Protein Tyrosine Phosphatases
Introduction
Scott Pluskey is a notable inventor based in Allston, MA (US). He has made significant contributions to the field of protein tyrosine phosphatases, particularly through his innovative research and patents. His work focuses on the development of novel mutant SH2 domain-containing protein tyrosine phosphatases, which have unique properties compared to their wildtype counterparts.
Latest Patents
Scott Pluskey holds a patent for "Activated mutants of SH2-domain-containing protein tyrosine phosphatases." This invention relates to novel mutant SH2 domain-containing protein tyrosine phosphatases that are partially or constitutively active. These mutants exhibit different abilities to regulate biological processes compared to the wildtype protein tyrosine phosphatases. The patent also covers methods for using these novel mutants, such as in vitro assays to screen for binding partners and inhibitors of protein tyrosine phosphatases, as well as potential treatments for diseases or conditions mediated by protein tyrosine phosphatases.
Career Highlights
Throughout his career, Scott Pluskey has worked with esteemed institutions, including Beth Israel Deaconess Medical Center, Inc. and Joslin Diabetes Center, Inc. His research has contributed to advancements in understanding protein tyrosine phosphatases and their role in various biological processes.
Collaborations
Scott has collaborated with notable colleagues, including Benjamin G Neel and Alana M O'Reilly. These partnerships have further enriched his research and innovation in the field.
Conclusion
Scott Pluskey is a distinguished inventor whose work on protein tyrosine phosphatases has the potential to impact various medical applications. His innovative approach and dedication to research continue to drive advancements in this important area of study.